Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-061724
Filing Date
2020-12-03
Accepted
2020-12-03 20:59:53
Documents
2
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9292
2 POA DOCUMENT poa.txt EX-24.3_948403 3099
  Complete submission text file 0001209191-20-061724.txt   13884
Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Thompson Peter A. (Reporting) CIK: 0001357522 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39756 | Film No.: 201368408

Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations